D-501-2013 Class II Terminated

Recalled by Hospira Inc. — Lake Forest, IL

FDA drug recall D-501-2013 was initiated by Hospira Inc. on May 16, 2013 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. The recall status is terminated (terminated Nov 10, 2014). Affected quantity: 95,700 vials.

Recall Details

Product Type
Drugs
Report Date
Jun 12, 2013
Initiation Date
May 16, 2013
Termination Date
Nov 10, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
95,700 vials

Product Description

Diazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, NDC 0409-3213-12

Reason for Recall

Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.

Distribution Pattern

Nationwide and Puerto Rico

Code Information

17-099-EV Exp 05/14

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-501-2013
openFDA file date
Oct 27, 2026
Loaded by RegDataLab
Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.